For more information, refer to the full study in Nature Communications.

After the authorization to open the residency, the UPR School of Medicine takes steps to avoid falling into the mistakes of ...

Alannah Moran, from Co Wicklow, is undergoing chemotherapy following two surgeries to remove the tumour last year. She is ...

A new drug-free, minimally invasive intervention targets the root cause of progressive loss of neural function in spinal ...

A new drug-free, minimally invasive intervention targets the root cause of progressive loss of neural function in spinal muscle atrophy (SMA), an inherited neuromuscular disease.

In a small human trial in SMA patients neurostimulation sessions improved motoneuron function, reduced fatigue, and improved leg muscle strength and walking.

Everyone has probably dealt with at least a little physical pain in their life.But fortunately, the number of peop ...

Spinal neurosurgeon Xiaofei (Sophie) Zhou, MD, is a pioneer within Cleveland-based University Hospitals. She started her 2025 by bringing endoscopic spine tools to the hospital and performed the ...

The GLP-1 drug, exenatide, has no positive impact on the movement, symptoms or brain imaging of people with Parkinson's, ...

A research team has identified a critical event driving tumor growth in a type of medulloblastoma -- and a way to block it.

A new opioid-free pain medication was approved by the FDA on Thursday, marking a non-addictive alternative for patients.

The GLP-1 drug, exenatide, has no positive impact on the movement, symptoms or brain imaging of people with Parkinson's, finds a new study led by UCL researchers.